| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |